Barely Significant
← all excerpts

ERCC1 as a biomarker for bladder cancer patients likely to benefit from adjuvant chemotherapy.

BMC Cancer · 2012 · PMC3404914 · PMID 22616552

Europe PMCDOI
1
hedged sentence
0.2000
closest p · 4.0× alpha
0.2000
boldest claim

The sentences

borderline significanceP = 0.20not close (p > 0.1)
The interaction term between ERCC1 expression and adjuvant chemotherapy showed borderline significance for disease-free survival (P = 0.20).

also in 7,017 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.